Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:36:53 EDT Thu 03 Oct 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

News for C:MDNA from 2023-10-04 to 2024-10-03 - 38 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-09-26 18:27C:MDNAMedicenna Therapeutics Corp1.88News ReleaseMedicenna Therapeutics holders approve AGM resolutions
2024-09-09 16:40C:MDNAMedicenna Therapeutics Corp2.22News ReleaseMedicenna presents preclinical results in France
2024-08-27 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J2.16News ReleaseMedicenna Announces Upcoming Presentations at The Promise of Interleukin-2 Therapy Conference
2024-08-15 15:46C:MDNAMedicenna Therapeutics Corp2.13News ReleaseMedicenna Therapeutics appoints Lalji to board
2024-08-01 07:00C:MDNAMEDICENNA THERAPEUTICS CORP. J2.13News ReleaseMedicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy
2024-07-31 21:27C:MDNAMedicenna Therapeutics Corp2.13SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-31 21:27C:MDNAMedicenna Therapeutics Corp2.13SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-26 16:52C:MDNAMedicenna Therapeutics Corp2.22MiscellaneousMedicenna Therapeutics has change in transfer agent
2024-06-27 18:36C:MDNAMedicenna Therapeutics Corp1.98News ReleaseMedicenna's March 31 cash position at $17-million
2024-06-27 00:52C:MDNAMedicenna Therapeutics Corp2.07SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-27 00:39C:MDNAMedicenna Therapeutics Corp2.07SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-27 00:39C:MDNAMedicenna Therapeutics Corp2.07SEDAR MD & ASEDAR MD & A
2024-06-26 12:40C:MDNAMedicenna Therapeutics Corp2.07News ReleaseMedicenna receives EMA approval for Ability-1 trial
2024-06-03 12:30C:MDNAMedicenna Therapeutics Corp2.57News ReleaseMedicenna presents phase 2b bizaxofusp results at ASCO
2024-05-13 11:55C:MDNAMedicenna Therapeutics Corp2.47News ReleaseMedicenna denies breaking ASCO prior-publication policy
2024-04-30 14:50C:MDNAMedicenna Therapeutics Corp2.31News ReleaseMedicenna closes $20M investment from RA Capital
2024-04-26 09:09C:MDNAMedicenna Therapeutics Corp2.49News ReleaseMedicenna arranges $20M private placement
2024-04-26 08:09C:MDNAMedicenna Therapeutics Corp1.95Resume TradingMedicenna Therapeutics resuming at the open
2024-04-26 08:02C:MDNAMedicenna Therapeutics Corp1.95Halt TradingMedicenna Therapeutics halted at the open
2024-04-09 16:57C:MDNAMedicenna Therapeutics Corp1.50News ReleaseMedicenna presents MDNA11 clinical data at AACR
2024-04-09 15:21C:MDNAMedicenna Therapeutics Corp1.70News ReleaseMedicenna presents preclinical data on MDNA113 at AACR
2024-02-14 12:43C:MDNAMedicenna Therapeutics Corp0.86News ReleaseMedicenna Therapeutics' Dec. 31 cash at $21.8-million
2024-02-14 07:40C:MDNAMedicenna Therapeutics Corp0.66SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-02-14 07:40C:MDNAMedicenna Therapeutics Corp0.66SEDAR Interim MD & ASEDAR Interim MD & A
2024-02-13 11:13C:MDNAMedicenna Therapeutics Corp0.67News ReleaseMedicenna doses first patient in combo Ability-1 study
2024-01-12 17:41C:MDNAMedicenna Therapeutics Corp0.40News ReleaseMedicenna appoints MNP as auditor
2024-01-09 10:36C:MDNAMedicenna Therapeutics Corp0.43News ReleaseMedicenna begins enrolment for Ability combo study
2023-12-21 19:39C:MDNAMedicenna Therapeutics Corp0.41News ReleaseMedicenna has conditional TSX OK for warrant extension
2023-12-19 10:10C:MDNAMedicenna Therapeutics Corp0.415News ReleaseMedicenna begins trading on OTCQB Venture Market
2023-11-17 11:15C:MDNAMedicenna Therapeutics Corp0.44News ReleaseMedicenna talks survival benefit in bizaxofusp trial
2023-11-14 14:43C:MDNAMedicenna Therapeutics Corp0.53News ReleaseMedicenna Therapeutics' Sept. 30 cash at $25.7-million
2023-11-14 08:42C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 08:38C:MDNAMedicenna Therapeutics Corp0.53SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-06 10:03C:MDNAMedicenna Therapeutics Corp0.435News ReleaseMedicenna presents phase 1 MDNA11 study data at SITC
2023-11-03 12:07C:MDNAMedicenna Therapeutics Corp0.25News ReleaseMedicenna details preclinical MDNA113 data at SITC
2023-10-27 10:05C:MDNAMedicenna Therapeutics Corp0.335News ReleaseMedicenna receives Nasdaq delisting notice
2023-10-25 09:48C:MDNAMedicenna Therapeutics Corp0.36News ReleaseMedicenna doses first patient in Ability dose expansion
2023-10-10 13:17C:MDNAMedicenna Therapeutics Corp0.39News ReleaseMedicenna appoints Gardner chief medical officer